Although CRP is inadequate indicator for treatment of COVID-19 because CRP production by IL-6 pathway is suppressed by TCZ, LDH, which indicates lung injury and severity of COVID-19 [28], also showed a decreasing trend. This evidence concerns the gene IL6 and COVID-19.